KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Gross Profit (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Gross Profit for 7 consecutive years, with $390.1 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 394.42% to $390.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $739.3 million through Dec 2025, up 73.86% year-over-year, with the annual reading at $739.3 million for FY2025, 73.86% up from the prior year.
  • Gross Profit hit $390.1 million in Q4 2025 for GoodRx Holdings, up from $112.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $390.1 million in Q4 2025 to a low of -$132.5 million in Q4 2024.
  • Historically, Gross Profit has averaged $135.4 million across 5 years, with a median of $118.3 million in 2025.
  • Biggest five-year swings in Gross Profit: plummeted 228.78% in 2024 and later soared 394.42% in 2025.
  • Year by year, Gross Profit stood at $106.8 million in 2021, then decreased by 6.35% to $100.0 million in 2022, then increased by 2.91% to $102.9 million in 2023, then tumbled by 228.78% to -$132.5 million in 2024, then skyrocketed by 394.42% to $390.1 million in 2025.
  • Business Quant data shows Gross Profit for GDRX at $390.1 million in Q4 2025, $112.5 million in Q3 2025, and $118.2 million in Q2 2025.